Hosted on MSN
Suncheonhyang University Cheonan Hospital acquires Grade 1 evaluation of the adequacy of chronic obs...
Cheonan Hospital (Hospital Director Lee Moon-soo) affiliated with Soonchunhyang University announced on the 3rd that it has obtained the first grade in both chronic obstructive ... maintains a ...
South Carolina high schools posted their highest graduation rate in a decade, but about a quarter of students still aren’t ...
Stallion Spotlight offers stud farm representatives a chance to address breeders and answer questions as they plan their ...
Generation Gold Corp. Class A ( ($TSE:GEN) ) has provided an announcement. Generation Uranium Inc. has identified the VGR Trend within its Yath ...
Five-time Eclipse Award-winning trainer Chad Brown won his 36th individual training title on The New York Racing Association, ...
Zocilurtatug pelitecan shows promising results as a DLL3-targeted therapy for small cell lung cancer, with high response rates and ongoing trials.
Opinion
10hon MSNOpinion
How Cristobal’s UM work compares to others in his pay grade. What he must do now
A look at how Mario Cristobal’s performance at Miami has compared with other coaches in his pay range and what must be fixed.
LUND, SE / ACCESS Newswire / November 3, 2025 / BioInvent International AB ("BioInvent") (STO:BINV)(Nasdaq Stockholm:BINV), a biotech company focused on the discovery and development of novel and firs ...
It’s been an up and down season for the Pirates to date. With two monster victories, a narrow win a tight loss and a big defeat, the Pirates have come unstuck against the top two. Back-rower Rasaku ...
First clinical data disclosure for CB-011 highlights its potential as a best-in-class allogeneic CAR-T cell therapy for relapsed or refractory ...
12hon MSN
The curious case of AJ Dybantsa: How an elite NBA prospect from Massachusetts ended up at BYU
On a recent Field of 68 podcast, NBA draft analyst Tyler Metcalf described AJ as performing like he had a case of “senioritis.” ESPN’s Jonathan Givony and Jeremy Woo also characterized Dybantsa’s ...
Third Point's Q3 2025 letter details a 3.2% net return, driven by AI/semiconductor gains and new investments. It also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results